دورية أكاديمية

Technetium-99m labeled core shell hyaluronate nanoparticles as tumor responsive, metastatic skeletal lesion targeted combinatorial theranostics.

التفاصيل البيبلوغرافية
العنوان: Technetium-99m labeled core shell hyaluronate nanoparticles as tumor responsive, metastatic skeletal lesion targeted combinatorial theranostics.
المؤلفون: Kaur S; Nanomedicine Laboratory, Department of Biosciences & Bioengineering, Indian Institute of Technology, Bombay, Mumbai 400076, India., Balakrishnan B; Nanomedicine Laboratory, Department of Biosciences & Bioengineering, Indian Institute of Technology, Bombay, Mumbai 400076, India; Nanotherapeutics & Biosensor Section, Chemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India. Electronic address: bbalakrishnan512@gmail.com., Mallia MB; Radiopharmaceutical Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India; Homi Bhabha National Institute, Mumbai 400094, India., Keshari R; Nanomedicine Laboratory, Department of Biosciences & Bioengineering, Indian Institute of Technology, Bombay, Mumbai 400076, India., Hassan PA; Nanotherapeutics & Biosensor Section, Chemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India; Homi Bhabha National Institute, Mumbai 400094, India., Banerjee R; Nanomedicine Laboratory, Department of Biosciences & Bioengineering, Indian Institute of Technology, Bombay, Mumbai 400076, India.
المصدر: Carbohydrate polymers [Carbohydr Polym] 2023 Jul 15; Vol. 312, pp. 120840. Date of Electronic Publication: 2023 Mar 23.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Applied Science Publishers Country of Publication: England NLM ID: 8307156 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1344 (Electronic) Linking ISSN: 01448617 NLM ISO Abbreviation: Carbohydr Polym Subsets: MEDLINE
أسماء مطبوعة: Publication: <1992-> : Barking : Elsevier Applied Science Publishers
Original Publication: London [Eng.] : Applied Science Publishers, c1981-
مواضيع طبية MeSH: Nanoparticles*/chemistry , Neoplasms*, Humans ; Technetium/chemistry ; Alendronate ; Precision Medicine ; Palmitic Acid ; Glycosaminoglycans ; Cell Line, Tumor ; Tumor Microenvironment
مستخلص: Achieving target specific delivery of chemotherapeutics in metastatic skeletal lesions remains a major challenge. Towards this, a dual drug loaded, radiolabeled multi-trigger responsive nanoparticles having partially oxidized hyaluronate (HADA) conjugated to alendronate shell and palmitic acid core were developed. While the hydrophobic drug, celecoxib was encapsulated in the palmitic acid core, the hydrophilic drug, doxorubicin hydrochloride was linked to the shell via a pH responsive imine linkage. Hydroxyapatite binding studies showed affinity of alendronate conjugated HADA nanoparticles to bones. Enhanced cellular uptake of the nanoparticles was achieved via HADA-CD44 receptor binding. HADA nanoparticles demonstrated trigger responsive release of encapsulated drugs in the presence of hyaluronidase, pH and glucose, present in excess in the tumor microenvironment. Efficacy of the nanoparticles for combination chemotherapy was established by >10-fold reduction in IC 50 of drug loaded particles with a combination index of 0.453, as compared to free drugs in MDA-MB-231 cells. The nanoparticles could be radiolabeled with the gamma emitting radioisotope technetium-99m ( 99m Tc) through a simple, 'chelator free', procedure with excellent radiochemical purity (RCP) (>90 %) and in vitro stability. 99m Tc-labeled drug loaded nanoparticles reported herein constitutes a promising theranostic agent to target metastatic bone lesions. STATEMENT OF HYPOTHESES: Technetium-99m labeled, alendronate conjugated, dual targeting, tumor responsive, hyaluronate nanoparticle for tumor specific drug release and enhanced therapeutic effect, with real-time in vivo monitoring.
Competing Interests: Declaration of competing interest Authors declare no competing financial interests or personal relationships to influence the work reported in this paper.
(Copyright © 2023 Elsevier Ltd. All rights reserved.)
فهرسة مساهمة: Keywords: Alendronate; Bone metastasis; Celecoxib PubChem CID 2662; Doxorubicin hydrochloride PubChem CID 443939; Hyaluronate; Radiolabeling; Sodium alendronate PubChem CID 23681107; Sodium hyaluronate PubChem CID 3084049; Technetium Tc-99m PubChem CID 26476; Trigger responsive
المشرفين على المادة: 7440-26-8 (Technetium)
0 (technetium Tc 99m alendronate)
X1J18R4W8P (Alendronate)
2V16EO95H1 (Palmitic Acid)
0 (Glycosaminoglycans)
تواريخ الأحداث: Date Created: 20230414 Date Completed: 20230418 Latest Revision: 20230418
رمز التحديث: 20230418
DOI: 10.1016/j.carbpol.2023.120840
PMID: 37059565
قاعدة البيانات: MEDLINE